tiprankstipranks
Advertisement
Advertisement

EW Stock Latest News

Oppenheimer downgrades AtriCure on new competition from Edwards
The FlyOppenheimer downgrades AtriCure on new competition from Edwards
1M ago
EW
ATRC
Early notable gainers among liquid option names on February 17th
PremiumThe Fly
Early notable gainers among liquid option names on February 17th
1M ago
EW
LUV
Edwards Lifesciences price target lowered to $90 from $94 at UBS
PremiumThe Fly
Edwards Lifesciences price target lowered to $90 from $94 at UBS
1M ago
EW
Edwards Lifesciences Leans Into Growth After Strong Quarter
PremiumCompany Announcements
Edwards Lifesciences Leans Into Growth After Strong Quarter
1M ago
EW
Edwards Lifesciences price target lowered to $89 from $92 at Truist
PremiumThe Fly
Edwards Lifesciences price target lowered to $89 from $92 at Truist
1M ago
EW
Edwards Lifesciences price target lowered to $87 from $90 at Baird
PremiumThe FlyEdwards Lifesciences price target lowered to $87 from $90 at Baird
1M ago
EW
Edwards Lifesciences: Capitalizing on TAVR Tailwinds, New Structural Heart Catalysts, and Attractive Valuation Upside
Premium
Ratings
Edwards Lifesciences: Capitalizing on TAVR Tailwinds, New Structural Heart Catalysts, and Attractive Valuation Upside
1M ago
EW
Edwards Lifesciences: Sustained TAVR Momentum, Margin Upside, and New LAAC Growth Support Buy Rating
Premium
Ratings
Edwards Lifesciences: Sustained TAVR Momentum, Margin Upside, and New LAAC Growth Support Buy Rating
1M ago
EW
Buy Rating on Edwards Lifesciences Driven by Strong Core TAVR Momentum, Conservative 2026 Guidance, and Attractive Risk‑Reward Profile
PremiumRatings
Buy Rating on Edwards Lifesciences Driven by Strong Core TAVR Momentum, Conservative 2026 Guidance, and Attractive Risk‑Reward Profile
1M ago
EW
Edwards Lifesciences price target lowered to $95 from $108 at Goldman Sachs
PremiumThe Fly
Edwards Lifesciences price target lowered to $95 from $108 at Goldman Sachs
1M ago
EW
Edwards Lifesciences price target raised to $100 from $98 at Piper Sandler
PremiumThe Fly
Edwards Lifesciences price target raised to $100 from $98 at Piper Sandler
1M ago
EW
AtriCure downgraded to Neutral from Overweight at JPMorgan
PremiumThe Fly
AtriCure downgraded to Neutral from Overweight at JPMorgan
1M ago
EW
MDT
Closing Bell Movers: Robinhood slips 8% after revenue miss
PremiumThe FlyClosing Bell Movers: Robinhood slips 8% after revenue miss
1M ago
F
Z
Edwards Lifesciences reports Q4 adjusted EPS 58c, consensus 62c
Premium
The Fly
Edwards Lifesciences reports Q4 adjusted EPS 58c, consensus 62c
1M ago
EW
Edwards Lifesciences sees Q1 adjusted EPS 70c-76c, consensus 69c
Premium
The Fly
Edwards Lifesciences sees Q1 adjusted EPS 70c-76c, consensus 69c
1M ago
EW
Edwards Lifesciences backs FY26 EPS view $2.90-$3.05, consensus $2.91
PremiumThe Fly
Edwards Lifesciences backs FY26 EPS view $2.90-$3.05, consensus $2.91
1M ago
EW
Edwards Lifesciences options imply 5.3% move in share price post-earnings
PremiumThe Fly
Edwards Lifesciences options imply 5.3% move in share price post-earnings
1M ago
EW
Notable companies reporting after market close
PremiumThe Fly
Notable companies reporting after market close
1M ago
Z
EW
These Are the Stocks Reporting Earnings Today – February 10, 2026
PremiumMarket News
These Are the Stocks Reporting Earnings Today – February 10, 2026
1M ago
F
Z
Is EW a Buy, Before Earnings?
PremiumPre-EarningsIs EW a Buy, Before Earnings?
2M ago
EW
Edwards Lifesciences price target lowered to $94 from $95 at UBS
Premium
The Fly
Edwards Lifesciences price target lowered to $94 from $95 at UBS
2M ago
EW
Edwards Lifesciences: Buy Rating Backed by Favorable TAVR Reimbursement Outlook and Asymptomatic Coverage Upside
Premium
Ratings
Edwards Lifesciences: Buy Rating Backed by Favorable TAVR Reimbursement Outlook and Asymptomatic Coverage Upside
2M ago
EW

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >